Literature DB >> 8774477

In situ hybridization and flow cytometric analysis of colorectal tumours suggests two routes of tumourigenesis characterized by gain of chromosome 7 or loss of chromosomes 17 and 18.

J Herbergs1, A H Hopman, A P De Bruïne, F C Ramaekers, J W Arends.   

Abstract

Chromosomal aberrations in colonic tumourigenesis were investigated by fluorescence in situ hybridization (FISH) with centromere-specific DNA probes and correlated to flow cytometry (FCM) results in a series of tissues including normal colonic epithelium, adenomas, and carcinomas, as well as adenomas adjacent to carcinomas. No numerical chromosome aberrations were detected in normal colonic epithelium, except for an extra chromosome X in one case. In the adenomas, the most frequently occurring chromosome aberration was a trisomy for chromosome 7, occurring in 37 per cent of the cases. In the carcinomas, two distinct routes of genetic aberration could be established on the basis of correlation with FCM: one with and one without endoreduplication. In the carcinomas without endoreduplication, trisomy or tetrasomy for chromosome 7 was detected in 12 out of 15 cases (80 per cent). In three of these cases, trisomy 7 was found in combination with loss of chromosome 17 and/or chromosome 18. In 87 per cent of the carcinomas with endoreduplication, loss of chromosome 17 and/or 18 was found, while in only one case was gain of chromosome 7 detected. In the adenomas adjacent to carcinomas, trisomy 7 was found in 36 per cent of the cases. In these cases, the concomitant adenocarcinomas showed the same numerical chromosome 7 aberration, plus extra aberrations for other chromosomes. In only two cases the carcinoma demonstrated trisomy 7 with a normal adjacent adenoma. These results suggest that gain of chromosome 7 is a significant aberration in the tumourigenesis of colonic carcinomas in which no endoreduplication has occurred. No marked clinico-pathological differences were observed between tumours of either route of tumourigenesis in this series.

Entities:  

Mesh:

Year:  1996        PMID: 8774477     DOI: 10.1002/(SICI)1096-9896(199607)179:3<243::AID-PATH588>3.0.CO;2-Q

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer.

Authors:  Manisha Juneja; Katharina Ilm; Peter M Schlag; Ulrike Stein
Journal:  Mol Oncol       Date:  2013-06-06       Impact factor: 6.603

2.  Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation.

Authors:  G A Meijer; M A Hermsen; J P Baak; P J van Diest; S G Meuwissen; J A Beliën; J M Hoovers; H Joenje; P J Snijders; J M Walboomers
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

Review 3.  MACC1 - more than metastasis? Facts and predictions about a novel gene.

Authors:  Ulrike Stein; Mathias Dahlmann; Wolfgang Walther
Journal:  J Mol Med (Berl)       Date:  2009-09-30       Impact factor: 4.599

4.  General aspects of colorectal cancer.

Authors:  Josep J Centelles
Journal:  ISRN Oncol       Date:  2012-11-14

5.  A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients.

Authors:  Alois H Lang; Simone Geller-Rhomberg; Thomas Winder; Nicole Stark; Klaus Gasser; Bernd Hartmann; Bertram Kohler; Ina Grizelj; Heinz Drexel; Axel Muendlein
Journal:  BMC Cancer       Date:  2012-01-17       Impact factor: 4.430

6.  Metastasis-associated in colon cancer 1 is a novel survival-related biomarker for human patients with renal pelvis carcinoma.

Authors:  Hailong Hu; Dawei Tian; Tao Chen; Ruifa Han; Yan Sun; Changli Wu
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.